Researchers discovered that excess testosterone (a male hormone) affects how the liver handles fat in surprising ways. When women or people assigned female at birth have high testosterone levels and eat a high-calorie diet, their livers actually store less fat—which sounds good. However, the testosterone causes the body to release more fat into the bloodstream, which isn’t healthy overall. This study helps explain why people with conditions like PCOS (polycystic ovary syndrome) that cause high testosterone often struggle with metabolic health, even when their livers look okay on the surface.

The Quick Take

  • What they studied: How excess testosterone changes the way livers process and store fat, especially when eating a high-calorie diet
  • Who participated: Female mice of similar age and weight, some treated with extra testosterone and some without, all fed either normal or high-calorie diets
  • Key finding: Testosterone reduced fat buildup in the liver but increased fat in the bloodstream—a trade-off that isn’t actually beneficial for overall health
  • What it means for you: If you have high testosterone (from PCOS, hormone therapy, or other causes), your liver may look healthier on tests, but your body may still be struggling with fat metabolism. This suggests the problem is more complex than just liver fat storage.

The Research Details

Scientists used female mice and gave some of them extra testosterone (called DHT) while keeping others as controls. They fed both groups either normal food or a high-calorie Western-style diet. They then measured fat levels in the liver and blood, and examined how genes and proteins were working in the liver cells.

The researchers used advanced technology to look at thousands of genes at once to understand which biological pathways were being activated or turned off by the testosterone. They also tested what happened when they changed how growth hormone (a different hormone) was delivered to the body.

This approach allowed them to trace the exact chain of events—from testosterone entering cells, to which genes turned on or off, to the final effects on fat storage and blood fat levels.

Understanding the exact mechanism is important because it explains why people with high testosterone often have metabolic problems even when their liver fat looks normal on scans. It also shows that protecting the liver from fat isn’t the same as protecting overall health, and that different hormones work together in complex ways.

This is a controlled laboratory study using animal models, which allows researchers to carefully control variables and trace biological mechanisms. However, results in mice don’t always translate directly to humans. The study provides strong mechanistic evidence but would need human studies to confirm these findings apply to people. The research was published in a respected journal focused on lipid science.

What the Results Show

When female mice received extra testosterone and ate a high-calorie diet, their livers accumulated significantly less fat compared to mice without extra testosterone. This initially seems protective. However, these same testosterone-treated mice had much higher levels of fat (triglycerides) circulating in their blood.

The researchers discovered that testosterone wasn’t working through the expected pathway (the androgen receptor in liver cells). Instead, it was working through a completely different mechanism involving growth hormone signaling. Testosterone made the liver cells activate a protein called STAT5, which then reduced the expression of a fat-transporter protein (CD36) that normally brings fatty acids into liver cells.

With less CD36, the liver couldn’t pull in as much fat from the blood, so fat accumulated less in the liver. But this fat had to go somewhere—it stayed in the bloodstream and was packaged into particles that the liver sent out into circulation (VLDL). This created a situation where the liver looked metabolically healthy, but the whole body was dealing with more circulating fat.

The study found that testosterone altered the composition of fatty acids in the liver, changing which types of fats were present. When researchers mimicked the normal female pattern of growth hormone release (continuous rather than pulsatile), it reversed the testosterone effects by reducing STAT5 activation and restoring CD36 expression. This shows that the testosterone effect depends on how growth hormone is being released.

Previous research showed conflicting results about whether testosterone affects liver fat. This study helps explain why—the effects depend heavily on diet (high-calorie vs. normal) and on growth hormone patterns. It also clarifies that testosterone’s effects on glucose (blood sugar) and liver fat are separate problems caused by different mechanisms, which explains why people with high testosterone often have multiple metabolic issues simultaneously.

This study was conducted in mice, not humans, so the results may not apply exactly the same way to people. The researchers used a specific form of testosterone (DHT) and specific mouse strains, so results might differ with other hormones or genetic backgrounds. The study focused on liver tissue and blood measurements but didn’t examine long-term health outcomes like heart disease or diabetes development. Additionally, the study used relatively short treatment periods, so it’s unclear if these effects persist long-term.

The Bottom Line

If you have high testosterone levels (from PCOS, congenital adrenal hyperplasia, or gender-affirming hormone therapy), this research suggests you should monitor both liver health AND blood fat levels, not just one or the other. Work with your doctor to manage overall metabolic health through diet, exercise, and potentially medication. Don’t assume your liver is healthy just because liver fat scans look normal. (Confidence: Moderate—based on animal research, needs human confirmation)

This is most relevant for people with PCOS, congenital adrenal hyperplasia, or those taking testosterone for gender-affirming care. It’s also important for healthcare providers treating these conditions. People without high testosterone levels don’t need to apply these findings directly, though the general principle about monitoring multiple health markers applies to everyone.

The metabolic changes shown in this study occurred within weeks in mice. In humans, changes in blood fat levels might be noticeable within weeks to months of hormone changes, but long-term health impacts (like heart disease risk) develop over years. Improvements from lifestyle changes typically show up in blood tests within 4-8 weeks.

Want to Apply This Research?

  • Track triglyceride levels (blood fat) every 3 months if you have high testosterone, along with liver function tests. Note any changes in diet or hormone therapy to correlate with results.
  • Focus on reducing high-calorie foods and increasing physical activity, since this study shows that high testosterone combined with high-calorie eating creates the most problematic metabolic situation. Even moderate diet improvements may help reduce circulating fat levels.
  • Create a quarterly health tracking routine that includes blood work results, dietary patterns, and exercise frequency. Watch for trends in triglyceride levels rather than focusing on single measurements, since these can fluctuate.

This research is based on animal studies and has not yet been confirmed in humans. The findings should not be used to diagnose, treat, or manage any medical condition. If you have high testosterone levels, PCOS, or are undergoing hormone therapy, consult with your healthcare provider about appropriate monitoring and treatment. This article is for educational purposes only and does not replace professional medical advice. Always discuss any changes to your health management plan with your doctor.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Androgen Excess Uncouples Circulating and Hepatic Lipid Homeostasis in Females on a High-Calorie Diet.Journal of lipid research (2026). PubMed 41921854 | DOI